<DOC>
	<DOCNO>NCT00940940</DOCNO>
	<brief_summary>Varicella zoster virus part herpesvirus group cause chickenpox expose individual . The majority population seropositive virus . Reactivation varicella zoster virus occur 30 % general population 60 year old . Solid organ transplant recipient receive lifelong immunosuppression drug great risk reactivation herpesviruses include varicella zoster virus regardless age . The vaccine show effective preventing shingle general population . The investigator ' purpose determine well vaccine work patient renal replacement therapy post-transplant .</brief_summary>
	<brief_title>Safety Immunogenicity Zostavax Vaccine Patients Undergoing Living Donor Kidney Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Age 1865 year 2 . Listed likely list live donor kidney transplant within one month 1 . Previous receipt Zostavax</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>